deltatrials
Recruiting PHASE3 INTERVENTIONAL 4-arm NCT05719467

SAINT: Safe Induction of Labor Trial (SAINT)

A Double-blind Randomized Placebo-controlled Four-arm Trial to Assess the Efficacy of Oral Bicarbonate and Intravenous Butylscopolamine Bromide to Facilitate Spontaneous (Non-operative) Delivery in Pregnant Female Participants With Induction of Labor

Sponsor: Oslo University Hospital

Conditions Induced; Birth Labor Complication Pregnancy Related
Interventions Buscopan 20 MG/ML Injectable Solution Nacl 0.9% Placebo Sodium bicarbonate
Updated 4 times since 2023 Last updated: Apr 2, 2024 Started: Jan 3, 2023 Primary completion: Jan 31, 2025 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Induced; Birth and Labor Complication and is currently actively recruiting participants. Oslo University Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2023 – ~May 2024 · 14 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  3. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  4. Mar 2023 — May 2024 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oslo University Hospital
Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations